DCF — MARK TWAIN MEDICAL CENTER
Enterprise Value: $-165.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-165.8M
Enterprise Value
$-51.4M
PV of Cash Flows
$-114.4M
PV of Terminal Value
$-184.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $71.4M | $-10.9M | -15.0% | $-13.9M | $-12.7M |
| Year 2 | $73.5M | $-10.5M | -14.0% | $-13.6M | $-11.3M |
| Year 3 | $75.7M | $-10.1M | -13.0% | $-13.3M | $-10.0M |
| Year 4 | $78.0M | $-10.0M | -13.0% | $-13.3M | $-9.1M |
| Year 5 | $80.3M | $-10.1M | -13.0% | $-13.5M | $-8.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-165.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$69.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15804472070231812
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5